Food and Drug Administration Deputy Commissioner for Food Kyle Diamantas said his agency's agenda has support "from the very ...

The proposal, reiterated during DTAB’s 93rd meeting held on February 16, 2026, is designed to bring all antibiotics—both new ...

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights the latest cover story on the current state, and future, of therapeutic drug ...

What do atomic bombs and fentanyl have in common? As of December 15, 2025, they are both classified as “Weapons of Mass ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

US pharma major AbbVie (NYSE: ABBV) has filed a lawsuit seeking to narrow the definition of a “340B patient,” opening a new ...

AbbVie has filed a lawsuit against the U.S. government, seeking clearer ​guidance on patients eligible for a drug discount ...

A patient walks into a clinic and asks not about diabetes control, but about weight loss drug. He has seen the results online, heard the name of the drug, and now, with prices falling, wants it.

The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40% of the world’s population, significantly lowering the price of a costly medicine that ...

Three Indian firms launched generic semaglutide after patent expiry for diabetes and obesity treatment Sun Pharma markets Noveltreat and Sematrinity with weekly costs from Rs 750 to Rs 2,000 Zydus ...

https://www.thehindubusinessline.com/companies/generic-versions-of-novo-nordisks-semaglutide-begin-to-flow-priced-50-80-lower-than-the-innovator/article70769849.ece ...

With 90% of prescriptions in the US filled for generic drugs, there is growing concern that supplies of the medications could be in short supply due to the ongoing situation in the Strait of Hormuz, a ...